FAF
Fjarde Ap-fonden’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30
| Closed | -$5K | – | 502 |
|
|
2025
Q1 | $5K | Sell |
30
-9,800
| -100% | -$1.63M | ﹤0.01% | 519 |
|
|
2024
Q4 | $1.82M | Buy |
9,830
+4,200
| +75% | +$775K | 0.02% | 483 |
|
|
2024
Q3 | $1.11M | Buy |
+5,630
| New | +$1.11M | 0.01% | 501 |
|
|
2024
Q1 | $1.77M | Buy |
6,530
+1,800
| +38% | +$488K | 0.02% | 502 |
|
|
2023
Q4 | $1.12M | Buy |
4,730
+3,500
| +285% | +$827K | 0.01% | 511 |
|
|
2023
Q3 | $241K | Sell |
1,230
-1,800
| -59% | -$353K | ﹤0.01% | 532 |
|
|
2023
Q2 | $637K | Sell |
3,030
-1,000
| -25% | -$210K | 0.01% | 522 |
|
|
2023
Q1 | $813K | Sell |
4,030
-2,600
| -39% | -$525K | 0.01% | 511 |
|
|
2022
Q4 | $1.44M | Sell |
6,630
-6,700
| -50% | -$1.46M | 0.02% | 491 |
|
|
2022
Q3 | $2.85M | Hold |
13,330
| – | – | 0.04% | 456 |
|
|
2022
Q2 | $2.85M | Sell |
13,330
-5,900
| -31% | -$1.26M | 0.04% | 456 |
|
|
2022
Q1 | $5.46M | Sell |
19,230
-100
| -0.5% | -$28.4K | 0.05% | 368 |
|
|
2021
Q4 | $7.28M | Buy |
19,330
+3,530
| +22% | +$1.33M | 0.06% | 307 |
|
|
2021
Q3 | $6.52M | Sell |
15,800
-1,500
| -9% | -$619K | 0.06% | 328 |
|
|
2021
Q2 | $6.4M | Buy |
+17,300
| New | +$6.4M | 0.06% | 343 |
|